Richard Maury Stone MD

PubMed

• A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia.
  Srinivas Vinod Saladi, Swati Garg, Ellen L Weisberg, Abigail E Case, Wei Ni
  Molecular Therapy. Oncology. 2026-09-17
• Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-year survival of CALGB 10403 (alliance).
  Wellington F Silva, Jun Yin, Michaela Liedtke, David F Claxton, Noreen Fulton
  Blood Advances. 2026-08-25
• Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.
  Evan C Chen, Yiwen Liu, Hayden L Bell, Jeremy Ryan, Jason Wu
  Clinical Cancer Research. 2026-08-14

Journal Articles

• Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML  
  Daniel A Pollyea, Amir T Fathi, Geoffrey L Uy, Robert K Stuart, Mikkael A Sekeres, Courtney D DiNardo, Alice S Mims, Eyal C Attar, Richard M Stone, Hagop M Kantarjian,..., The New England Journal of Medicine
• NF1 Mutations Are Recurrent in Adult Acute Myeloid Leukemia and Confer Poor Outcome  
  Eunice S Wang, Bayard L Powell, Richard M Stone, John C Byrd, Clara D Bloomfield, Alice Mims, Andrew J Carroll, Jonathan E Kolitz, James S Blachly, Nature

Abstracts/Posters

• Tolerability and Efficacy of Crenolanib and Cytarabine/Anthracycline Chemotherapy in Older Patients (Aged 61 to 75) with Newly Diagnosed FLT3-Mutated Acute Myeloid Leu...
  Richard M. Stone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial
  Richard M. Stone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
  Richard Stone, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Crenolanib versus midostaurin combined with induction and consolidation chemotherapy in newly diagnosed mutated AML. 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
• Data + Perspectives: Exploring the Role of Novel Agents and Emerging Strategies in the Management of Acute Myeloid Leukemia 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Phase I Trial of Escalating Doses of the Bcl-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction and High Dose Cytarabine Consolidation in Pre... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Other

• Older Adults with Acute Myeloid Leukemia Treated with Intensive Chemotherapy: “Old” Prognostic Algorithms May Not Apply 
  Richard Stone, MD, Haematologica
  https://www.doximity.com/articles/b27bba2a-b21b-4ce6-8922-56d9b6b9b894
  UpToDate, Wolters Kluwer Health - 2013-04-10